T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Coherus Oncology
CHRS
$178M
| $166K | ﹤0.01% |
38,786
+1,444
| +4% | +$8.52K |
|
|
NKLA
2577
DELISTED
Nikola Corporation Common Stock
NKLA
| $166K | ﹤0.01% |
4,009
+1,873
| +88% | +$51.7K |
|
|
ESTE
2578
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $166K | ﹤0.01% |
+11,578
| New | +$155K |
|
|
BAND
2579
Bandwidth Inc
BAND
$1.74B
| $165K | ﹤0.01% |
12,061
-2,935
| -20% | -$37K |
|
2580
ProPetro Holding
PUMP
$1.42B
| $165K | ﹤0.01% |
19,987
+3,396
| +20% | +$24.9K |
|
2581
Cabaletta Bio
CABA
$445M
| $163K | ﹤0.01% |
+12,591
| New | +$137K |
|
2582
Omeros
OMER
$1.26B
| $163K | ﹤0.01% |
29,950
+7,750
| +35% | +$45.3K |
|
2583
ClearPoint Neuro
CLPT
$466M
| $162K | ﹤0.01% |
22,366
+4,666
| +26% | +$39.7K |
|
|
AHRT
2584
AH Realty Trust
AHRT
$507M
| $160K | ﹤0.01% |
13,665
+870
| +7% | +$10.1K |
|
2585
Quantum Corp
QMCO
$970M
| $159K | ﹤0.01% |
7,320
| – | – |
|
2586
MediaAlpha
MAX
$804M
| $157K | ﹤0.01% |
15,166
+539
| +4% | +$4.87K |
|
2587
ADMA Biologics
ADMA
$2.11B
| $155K | ﹤0.01% |
41,867
+2,118
| +5% | +$7.85K |
|
2588
Atea Pharmaceuticals
AVIR
$410M
| $155K | ﹤0.01% |
41,232
+1,488
| +4% | +$5.57K |
|
2589
Cullinan Oncology
CGEM
$1.29B
| $155K | ﹤0.01% |
14,402
+365
| +3% | +$3.88K |
|
2590
FTC Solar
FTCI
$40.6M
| $155K | ﹤0.01% |
4,785
+642
| +15% | +$17.7K |
|
2591
SES AI
SES
$214M
| $155K | ﹤0.01% |
63,260
+25,360
| +67% | +$49.1K |
|
|
QVCGA
2592
DELISTED
QVC Group Inc Series A
QVCGA
| $154K | ﹤0.01% |
3,095
-1,467
| -32% | -$66K |
|
|
NSTG
2593
DELISTED
NanoString Technologies, Inc.
NSTG
| $154K | ﹤0.01% |
37,817
+5,177
| +16% | +$38.2K |
|
|
LICY
2594
DELISTED
Li-Cycle Holdings Corp.
LICY
| $153K | ﹤0.01% |
3,426
+212
| +7% | +$8.66K |
|
2595
FuboTV Inc
FUBO
$297M
| $152K | ﹤0.01% |
6,052
-3,603
| -37% | -$69K |
|
2596
Nordic American Tanker
NAT
$1.41B
| $152K | ﹤0.01% |
41,326
+2,583
| +7% | +$9.33K |
|
|
LUCK
2597
Lucky Strike Entertainment
LUCK
$941M
| $152K | ﹤0.01% |
12,998
+159
| +1% | +$2.12K |
|
2598
Butterfly Network
BFLY
$2.46B
| $151K | ﹤0.01% |
65,279
+3,250
| +5% | +$7.26K |
|
2599
PMV Pharmaceuticals
PMVP
$65.6M
| $150K | ﹤0.01% |
23,961
+344
| +1% | +$1.8K |
|
|
TERN
2600
DELISTED
Terns Pharmaceuticals
TERN
| $149K | ﹤0.01% |
+16,986
| New | +$198K |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.